{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:18:30Z","timestamp":1789787910415,"version":"4.0.1"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.drugalcdep.2015.09.030","type":"journal-article","created":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T19:41:52Z","timestamp":1444938112000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":173,"special_numbering":"C","title":["Next generation of novel psychoactive substances on the horizon \u2013 A complex problem to face"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-2389","authenticated-orcid":false,"given":"Jolanta B.","family":"Zawilska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Andrzejczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0005","series-title":"\u201cNBOMe\u201d Compounds: A Review of the Evidence of Use and Harm","author":"ACMD (Advisory Council on the Misuse of Drugs)","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0010","series-title":"ACMD's Review on the Synthetic Opioid MT-45","author":"ACMD (Advisory Council on the Misuse of Drugs)","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0015","article-title":"Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography\u2013tandem mass spectrometry","author":"Adamowicz","year":"2015","journal-title":"Drug Test. Anal."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2015.09.030_bib0020","doi-asserted-by":"crossref","first-page":"S264","DOI":"10.1111\/1556-4029.12594","article-title":"Fatal intoxication with methoxetamine","volume":"60","author":"Adamowicz","year":"2015","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0025","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/15389588.2015.1018990","article-title":"The influence of synthetic cannabinoid UR-144 on human psychomotor performance \u2013 a case report demonstrating road traffic risks","volume":"16","author":"Adamowicz","year":"2015","journal-title":"Traffic Inj. Prev."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.forsciint.2014.10.016","article-title":"Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB)","volume":"245C","author":"Adamowicz","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0035","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2015.03.012","article-title":"A fatal poisoning involving 25C-NBOMe","volume":"251","author":"Andreasen","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00204-014-1278-7","article-title":"Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of \u2018legal high\u2019 packages containing synthetic cathinones","volume":"89","author":"Ara\u00fajo","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jat\/bku048","article-title":"Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22","volume":"38","author":"Behonick","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734749","article-title":"25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug","author":"Bersani","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0140-6736(09)60252-X","article-title":"Drug-induced fibrotic valvular heart disease","volume":"374","author":"Bhattacharyya","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0060","article-title":"Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage","author":"Bileck","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pbb.2015.03.007","article-title":"Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: evidence of its abuse potential","volume":"133","author":"Botanas","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0075","article-title":"In vitro characterization of potential CYO- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC\u2013high resolution MS","author":"Boumrah","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0080","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/mol.106.028720","article-title":"Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists","volume":"70","author":"Braden","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/dta.1668","article-title":"Characterization of a novel and potentially lethal designer drug (\u00b1)-cis-para-methyl-4-methylaminorex (4,4\u2032-DMAR, or \u2018Serotoni\u2019)","volume":"6","author":"Brandt","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/15563650.2014.932365","article-title":"Acute kidney injury associated with smoking synthetic cannabinoid","volume":"52","author":"Buser","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0095","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1007\/s00216-015-8828-6","article-title":"Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC\u2013MS, LC\u2013MSn, and LC\u2013HR-MS\/MS","volume":"407","author":"Caspar","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0100","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0105","first-page":"93","article-title":"Acute kidney injury associated with synthetic cannabinoid use \u2013 multiple States, 2012","volume":"62","author":"CDC (Centers for Disease Control Prevention)","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0110","first-page":"939","article-title":"Notes from the field: severe illness associated with synthetic cannabinoid use \u2013 Brunswick, Georgia, 2013","volume":"62","author":"CDC (Centers for Disease Control Prevention)","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s13181-013-0306-y","article-title":"Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis","volume":"9","author":"Chan","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/hup.2422","article-title":"Methoxetamine-related deaths in the UK: an overview","volume":"30","author":"Chiappini","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0125","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0130","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/cns.12063","article-title":"From \u201cSpecial K\u201d to \u201cSpecial M\u201d: the evolution of the recreational use of ketamine and methoxetamine","volume":"19","author":"Corazza","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/02791072.2014.944291","article-title":"\u201cSpice\u201d, \u201ckryptonite\u201d, \u201cblack mamba\u201d: an overview of brand names and marketing strategies of novel psychoactive substances on the web","volume":"46","author":"Corazza","year":"2014","journal-title":"J. Psychoact. Drugs"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2015.09.030_bib0140","first-page":"39","article-title":"Effects of methoxetamine in rat bladder and nucleus accumbens brain tissue","volume":"1","author":"Davidson","year":"2014","journal-title":"Res. Adv. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/15563650.2014.892605","article-title":"Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice","volume":"52","author":"Dargan","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pnpbp.2013.08.013","article-title":"The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat","volume":"48","author":"Dawson","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0155","first-page":"68716","article-title":"Schedules of controlled substances: temporary placement of three synthetic phenylethylamine into schedule I","volume":"78","author":"DEA (Drug Enforcement Administration, U.S. Department of Justice)","year":"2013","journal-title":"Fed. Reg."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0160","first-page":"7577","article-title":"Scheduled of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I","volume":"79","author":"DEA (Drug Enforcement Administration, U.S. Department of Justice)","year":"2014","journal-title":"Fed. Reg."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0165","first-page":"12938","article-title":"Scheduled of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I","volume":"79","author":"DEA (Drug Enforcement Administration, U.S. Department of Justice)","year":"2014","journal-title":"Fed. Reg."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0170","first-page":"5042","article-title":"Scheduled of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I","volume":"80","author":"DEA (Drug Enforcement Administration, U.S. Department of Justice)","year":"2015","journal-title":"Fed. Reg."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0175","first-page":"27611","article-title":"Scheduled of controlled substances: placement of UR-144, XLR11, and AKB48 into Schedule I","volume":"80","author":"DEA (Drug Enforcement Administration, U.S. Department of Justice)","year":"2015","journal-title":"Fed. Reg."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0180","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13181-013-0295-x","article-title":"2C or not 2C: phenethylamine designer drug review","volume":"9","author":"Dean","year":"2013","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0185","unstructured":"Drugs Forum. https:\/\/drugs-forum.com\/forum\/showwiki.php?title=a-PVP (accessed on 30.04.15)."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0190","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/1556-4029.12407","article-title":"A polydrug intoxication involving methoxetamine in a drugs and driving case","volume":"59","author":"Elian","year":"2014","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0195","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jat\/bkv006","article-title":"First reported fatalities associated with the \u2018research chemical\u2019 2-methoxydiphenidine","volume":"39","author":"Elliott","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lfs.2013.12.212","article-title":"Synthetic cannabinoids: analysis and metabolites","volume":"97","author":"ElSohly","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0205","series-title":"Methoxetamine. EMCDDA \u2013 Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino) cyclohexanone)","author":"EMCDDA","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0210","series-title":"European Drug Report 2014a. Trends and developments","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0215","series-title":"EMCDDA \u2013 Europol Joint Report on a new psychoactive substance: 4,4\u2032-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine)","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0220","series-title":"EMCDDA \u2013 Europol Joint Report on a new psychoactive substance: 25I-NBOMe (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl) phenethylamine)","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0225","series-title":"EMCDDA \u2013 Europol Joint Report on a new psychoactive substance: AH-7921 (3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl} benzamide)","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0230","series-title":"EMCDDA \u2013 Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (\u2018MT-45\u2019)","author":"EMCDDA","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0235","series-title":"New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015)","author":"EMCDDA","year":"2015"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0240","series-title":"Perspective on drugs. Synthetic cannabinoids in Europe","author":"EMCDDA","year":"2015"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0245","series-title":"\u03b1-PVP EMCDDA \u2013 Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (\u03b1-PVP)","author":"EMCDDA","year":"2015"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","article-title":"Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to \u0394(9)-THC: mechanism underlying greater toxicity?","volume":"97","author":"Fantegrossi","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/10550887.2014.950027","article-title":"NBOMe designer drug exposures reported to Texas poison centers","volume":"33","author":"Forrester","year":"2014","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0815","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/jm901214q","article-title":"Indol-3-yl-cycloalkylketones: effects of N1 substituted indole side chain variations on CB2 cannabinoid receptor activity","volume":"53","author":"Frost","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0260","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1208\/s12248-013-9516-0","article-title":"First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry","volume":"15","author":"Gandhi","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/FBP.0000000000000150","article-title":"\u03949-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market","volume":"26","author":"Gatch","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0270","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00213-014-3755-3","article-title":"Discriminative and locomotor effects of five synthetic cathinones in rats and mice","volume":"232","author":"Gatch","year":"2015","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0275","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s12024-015-9669-5","article-title":"Deaths linked to synthetic cannabinoids","volume":"11","author":"Gerostamoulos","year":"2015","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0280","series-title":"XXXII Conference of the Forensic Toxicologists","first-page":"51","article-title":"Analysis of \u03b1-PVP in biological samples","author":"Gil","year":"2015"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0285","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/hup.2472","article-title":"4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4\u2032-DMAR, 4,4\u2032-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity","volume":"30","author":"Glanville","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0290","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0295","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00063-014-0360-5","article-title":"Near fatal intoxication with the novel psychoactive substance 25C-NBOMe","volume":"109","author":"Grautoff","year":"2014","journal-title":"Med. Klin. Intensivmed. Notfmed."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0300","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/15563650.2014.925562","article-title":"\u2018Crazy Monkey\u2019 poisons man and dog: human and canine seizures due to PB-22, a novel synthetic cannabinoid","volume":"52","author":"Gugelmann","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0305","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0310","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuropharm.2013.08.025","article-title":"Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response","volume":"77","author":"Halberstadt","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0315","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1373\/clinchem.2012.194381","article-title":"Cannabis effects on driving skills","volume":"59","author":"Hartman","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0320","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1476-5381.1983.tb10011.x","article-title":"Determination of receptors that mediate opiate side effects in the mouse","volume":"79","author":"Hayes","year":"1983","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0325","series-title":"Synthese und Pharmakologie potenter 5-HT2A-Rezeptor agonisten mit N-2-Methoxybenzyl-Partialstructur. Entwicklung eines neuen Structur-Wirkungskonzepts","author":"Heim","year":"2003"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0330","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/15563650.2014.943908","article-title":"MT-45, a new psychoactive substance associated with hearing loss and unconsciousness","volume":"52","author":"Helander","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0335","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/15563650.2014.976792","article-title":"Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations","volume":"52","author":"Heyerdahl","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0340","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/15563650.2013.802795","article-title":"Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series","volume":"51","author":"Hill","year":"2013","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/emermed-2012-202251","article-title":"Methoxetamine toxicity reported to the National Poisons Information Service: clinical characteristics and patterns of enquiries (including the period of the introduction of the UK's first Temporary Class Drug Order)","volume":"31","author":"Hill","year":"2013","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0350","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.annemergmed.2011.11.018","article-title":"Ketamine-like effects after recreational use of methoxetamine","volume":"60","author":"Hofer","year":"2012","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0355","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1208\/s12248-015-9788-7","article-title":"CYP3A4 mediates oxidative metabolism of the synthetic cannabinoid AKB-48","volume":"17","author":"Holm","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0365","first-page":"235","article-title":"Acute methoxetamine poisoning \u2013 case report","volume":"91","author":"Hydzik","year":"2012","journal-title":"Probl. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2012.12.006","article-title":"Neurochemical profiles of some novel psychoactive substances","volume":"700","author":"Iversen","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0375","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/hup.2302","article-title":"Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (benzofury\/6-APB) and NRG-2 with review of available evidence-based literature","volume":"28","author":"Jebadurai","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0380","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jat\/bku085","article-title":"An evaluation of 25B-, 25C-, 25D-, 25H-, 25I-, and 25T2-NBOMe via LC\u2013MS\u2013MS: method validation and analyte stability","volume":"38","author":"Johnson","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0385","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2169\/internalmedicine.53.2344","article-title":"A multicenter retrospective survey of poisoning after consumption of products containing synthetic chemicals in Japan","volume":"53","author":"Kamijo","year":"2014","journal-title":"Intern. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0390","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3109\/15563650.2014.973115","article-title":"Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the \u2018benzofuran\u2019 compounds. A report from the United Kingdom National Poisons Information Service","volume":"52","author":"Kamour","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0395","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1570159X13666141210224137","article-title":"Synthetic cathinones: a new health problem","volume":"13","author":"Karila","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0400","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.forsciint.2014.11.012","article-title":"Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids","volume":"246","author":"Karinen","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0405","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.forsciint.2014.08.013","article-title":"Lethal poisonings with AH-7921 in combination with other substances","volume":"244","author":"Karinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0410","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.1570","article-title":"New phenethylamines in Europe","volume":"6","author":"King","year":"2013","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0415","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/02791072.2013.803647","article-title":"Methoxetamine (MXE) \u2013 a phenomenological study of experiences induced by a \u201clegal high\u201d from the internet","volume":"45","author":"Kjellgren","year":"2013","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0420","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.taap.2014.03.014","article-title":"Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8","volume":"277","author":"Koller","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0425","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.fct.2015.03.004","article-title":"Genotoxic properties of representatives of alkylindazoles and aminoalkyl-indoles which are consumed as synthetic cannabinoids","volume":"80","author":"Koller","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0430","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00204-013-1029-1","article-title":"Toxicological profiles of selective synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1","volume":"87","author":"Koller","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0435","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jat\/bku057","article-title":"Fatal intoxications associated with the designer opioid AH-7921","volume":"38","author":"Kronstrand","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0440","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.forsciint.2015.02.010","article-title":"25I-NBOMe related death in Australia: a case report","volume":"249","author":"Kueppers","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jms.3514","article-title":"Selective reagent ionisation-time of flight-mass spectrometry: a rapid technology for the novel analysis of blends of new psychoactive substances","volume":"50","author":"Lanza","year":"2015","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0450","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13181-014-0445-9","article-title":"Evolution of the NBOMes: 25C- and 25B-sold as 25I-NBOMe","volume":"11","author":"Laskowski","year":"2015","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0455","first-page":"618","article-title":"Increase in reported adverse health Effects related to synthetic cannabinoids use \u2013 United States, January\u2013May 2015","volume":"64","author":"Law","year":"2015","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0460","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1177\/0269881114523866","article-title":"The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample","volume":"28","author":"Lawn","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0465","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/1556-4029.12550","article-title":"Driving under the influence of synthetic cannabinoid receptor agonist XLR-11","volume":"59","author":"Lemos","year":"2014","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0470","first-page":"1712","article-title":"MT-45 \u2013 a dangerous and potentially ototoxic internet drug","volume":"111","author":"Lindeman","year":"2014","journal-title":"Lakartidningen"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0475","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jat\/bku067","article-title":"XLR-11 and UR-144 in Washington State and State of Alaska driving cases","volume":"38","author":"Louis","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0480","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/jat\/bkv092","article-title":"A case review of the first analytically confirmed 25I-NBOMe-related death in Washington State","volume":"39","author":"Lowe","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0485","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0490","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jat\/bku131","article-title":"Acute 5-(2-aminopropyl)benzofuran (5-APB) intoxication and fatality: a case report with postmortem concentrations","volume":"39","author":"McIntyre","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0495","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/dta.1732","article-title":"Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3\u2032,4\u2032-methylenedioxy-4-methylaminorex (MDMAR)","volume":"7","author":"McLaughlin","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0500","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/dta.1541","article-title":"Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamine","volume":"6","author":"Menzies","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0505","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00414-013-0864-1","article-title":"Driving under the influence of synthetic cannabinoids (\u201cSpice\u201d): a case series","volume":"128","author":"Musshoff","year":"2014","journal-title":"Int. J. Leg. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0510","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2013.12.262","article-title":"Sudden death after sustained restraint following self-administration of the designer drug \u03b1-pyrrolidinovalerophenone","volume":"172","author":"Nagai","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0515","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.drugalcdep.2015.02.002","article-title":"Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats","volume":"149","author":"Naylor","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0520","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1007\/s00216-015-8763-6","article-title":"In vitro phase I and phase II metabolism of \u03b1-pyrrolidinovalerophenone (\u03b1-PVP), methylenedioxypyrovalerone (MDPV) and methedrone by human liver microsomes and human liver cytosol","volume":"407","author":"Negreira","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0525","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1016\/j.bmc.2008.04.050","article-title":"High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand","volume":"16","author":"Nichols","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0530","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/01480545.2014.911882","article-title":"2C-I-NBOMe, an \u201cN-bomb\u201d that kills with \u201cSmiles\u201d. Toxicological and legislative aspects","volume":"38","author":"Nikolaou","year":"2015","journal-title":"Drug Chem. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2015.09.030_bib0535","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0024-3205(83)90534-9","article-title":"(1,2-Diphenylethyl) piperazines as potent opiate-like analgesics; the unusual relationships between stereoselectivity and affinity to opioid receptor","volume":"33","author":"Nozaki","year":"1983","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0540","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/YCO.0000000000000071","article-title":"Emerging drugs in Europe","volume":"27","author":"Papaseit","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0545","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jat\/bkv091","article-title":"Concentrations of AB-CHMINACA and AB-PINACA and driving behavior in suspected impaired driving cases","volume":"39","author":"Peterson","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0550","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.forsciint.2014.10.027","article-title":"Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone","volume":"245","author":"Pichini","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0555","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.forsciint.2013.10.015","article-title":"Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death","volume":"234","author":"Poklis","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0560","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/dta.1522","article-title":"Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)metyl]-dibenzeethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication","volume":"6","author":"Poklis","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0565","series-title":"XXXII Conference of the Forensic Toxicologists","first-page":"55","article-title":"Fatal intoxication with \u03b1-PVP","author":"Potocka-Bana\u015b","year":"2015"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0570","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.neuropharm.2015.08.034","article-title":"Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)","volume":"99","author":"Rickli","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0575","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1111\/bph.13128","article-title":"Pharmacological profile of novel psychoactive benzofurans","volume":"171","author":"Rickli","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0580","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/15563650.2013.772191","article-title":"A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug","volume":"51","author":"Rose","year":"2013","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0585","doi-asserted-by":"crossref","first-page":"e59334","DOI":"10.1371\/journal.pone.0059334","article-title":"The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor","volume":"8","author":"Roth","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0590","unstructured":"Rzeczpospolita. http:\/\/wiadomosci.onet.pl\/kraj\/diler-w-rozmowie-z-rzeczpospolita-chemicy-dali-ciala-z-mocarzem\/rb3wqp (accessed on 24.07.15)."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0595","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/npp.2014.325","article-title":"\u2018Second-generation\u2019 mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function","volume":"40","author":"Saha","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0600","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jemermed.2014.12.038","article-title":"A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA","volume":"48","author":"Schwartz","year":"2015","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0605","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1093\/jat\/bkv058","article-title":"Fatal intoxications with 25B-NBOMe and 25I-NBOMe in Indiana during 2014","volume":"39","author":"Shanks","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0610","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.forsciint.2015.04.021","article-title":"Case reports of synthetic cannabinoid XLR-11 associated fatalities","volume":"252","author":"Shanks","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0615","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11419-013-0202-9","article-title":"Metabolism of the newly encountered designer drug \u03b1-pyrrolidinovalerophenone in humans: identification and quantitation of urinary metabolites","volume":"32","author":"Shima","year":"2014","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0620","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/15563650.2014.983239","article-title":"Understanding the availability, prevalence of use, desired effects, acute toxicity and dependence potential of the novel opioid MT-45","volume":"53","author":"Siddiqi","year":"2015","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0625","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0630","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neuropharm.2013.11.008","article-title":"Monoamine transporter and receptor interaction profiles of a new series of designer cathinones","volume":"79","author":"Simmler","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0635","series-title":"XXXI Conference of the Forensic Toxicologists","first-page":"31","article-title":"Sudden cardiac death in the course of a complex intoxication with AH-7921, NEB, 3-MMC and pseudoephedrine \u2013 cardiotoxic activity of novel psychoactive substances","author":"Skowronek","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0640","unstructured":"SOS Polonia, 2015. http:\/\/www.sospolonia.net\/drug-warning-information-from-hampshire-constabulary (accessed 30.09.15)."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0645","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jchromb.2003.07.008","article-title":"Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4\u2032-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography\u2013mass spectrometry","volume":"796","author":"Springer","year":"2003","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0650","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3109\/15563650.2015.1054502","article-title":"NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System","volume":"53","author":"Srisuma","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0655","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13181-013-0314-y","article-title":"2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing","volume":"10","author":"Stellpflug","year":"2014","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0660","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/02791072.2014.960111","article-title":"\u201cMy friend said it was good LSD\u201d: a suicide attempt following analytically confirmed 25I-NBOMe ingestion","volume":"46","author":"Suzuki","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0665","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/jat\/bkv011","article-title":"A fatal case of pentedrone and \u03b1-pyrrolidinovalerophenone poisoning","volume":"39","author":"Sykutera","year":"2015","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0670","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3109\/15563650.2014.958614","article-title":"A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid","volume":"52","author":"Takematsu","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0675","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jchromb.2014.08.033","article-title":"Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC\u2013MS\/MS","volume":"969","author":"Tang","year":"2014","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0680","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/15563650.2014.909932","article-title":"Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe","volume":"52","author":"Tang","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0685","article-title":"Fatal intoxication with the new designer drug 25C-NBOMe","volume":"177","author":"Tarpgaard","year":"2015","journal-title":"Ugeskr. Laeger."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0690","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/dta.1731","article-title":"Synthetic cannabimimetic agents metabolized by carboxylesterases","volume":"7","author":"Thomsen","year":"2015","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0695","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2013.10.028","article-title":"Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death","volume":"274","author":"Tomiyama","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0700","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.aap.2013.09.009","article-title":"Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period","volume":"62","author":"Tuv","year":"2014","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0705","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.forsciint.2012.08.047","article-title":"URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products","volume":"227","author":"Uchiyama","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0710","series-title":"Worlds Drug Report 2013. New psychoactive substances: concepts and definitions","first-page":"60","author":"UNODC (United Nations Office on Drugs and Crime)","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0711","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jat\/bku021","article-title":"Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine","volume":"38","author":"Uralets","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0715","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/2210676611303020003","article-title":"Novel drugs of abuse: a snapshot of an evolving marketplace","volume":"3","author":"Vandrey","year":"2013","journal-title":"Adolesc. Psychiatry (Hilversum)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0720","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/02791072.2014.934979","article-title":"An Internet study of user's experiences of the synthetic cathinone 4-methylethcathinone (4-MEC)","volume":"46","author":"Van Hout","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0725","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/02791072.2014.974002","article-title":"\u201cWord of mouse\u201d: indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine","volume":"47","author":"Van Hout","year":"2015","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0730","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jat\/bku011","article-title":"A fatality involving AH-7921","volume":"38","author":"Vorce","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0735","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PAF.0000000000000082","article-title":"Pathological findings in 2 cases of fatal 25I-NBOMe toxicity","volume":"35","author":"Walterscheid","year":"2014","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0740","article-title":"Effects of \u03b1-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation \u201cbath salts,\u201d on intracranial self-stimulation thresholds in rats","author":"Watterson","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0745","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00216-014-8360-0","article-title":"Benzofuran analogues of amphetamine and methamphetamine: studies on metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC\u2013MS and LC\u2013(HR)-MSn techniques","volume":"407","author":"Welter","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0750","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1007\/s00216-015-8552-2","article-title":"Metabolic fate, mass spectra fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPD in comparison to their 5-isomers using GC\u2013MS and LC\u2013(HR)-MSn techniques","volume":"407","author":"Welter","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0755","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2478\/s13382-014-0290-8","article-title":"Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report","volume":"27","author":"Wiergowski","year":"2014","journal-title":"Int. J. Occup. Med. Environ. Health"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0760","series-title":"XXXII Conference of the Forensic Toxicologists","first-page":"35","article-title":"Description and diagnosis of acute intoxication with novel psychoactive substances 25B-NBOMe and 4-CMC","author":"Wiergowski","year":"2015"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0765","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jat\/bks086","article-title":"An accidental fatal intoxication with methoxetamine","volume":"37","author":"Wikstr\u00f6m","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0770","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2013.07.022","article-title":"Cannabinoids in disguise: \u03949-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles","volume":"75","author":"Wiley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0775","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1208\/s12248-015-9721-0","article-title":"Pentylindole\/pentylindazole synthetic cannabinoids and their 5-fluoro analogs produce different primary metabolites: metabolite profiling for AB-PINACA and 5F-AB-PINACA","volume":"17","author":"Wohlfarth","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0780","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00216-014-7668-0","article-title":"Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry","volume":"406","author":"Wohlfarth","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/15563650.2015.1004179","article-title":"Prevalence of use and acute toxicity associated with the use of NBOMe drugs","volume":"53","author":"Wood","year":"2015","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0790","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1874473711104020122","article-title":"\u201cLegal highs\u201d \u2013 new players in the old drama","volume":"4","author":"Zawilska","year":"2011","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0795","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.toxlet.2014.08.011","article-title":"Methoxetamine \u2013 a novel recreational drug with potent hallucinogenic properties","volume":"230","author":"Zawilska","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0800","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones \u2013 an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0805","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1017\/S1461145713001247","article-title":"Spice\/K2 drugs \u2013 more than innocent substitutes for marijuana","volume":"17","author":"Zawilska","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.09.030_bib0810","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.forsciint.2012.08.027","article-title":"25C-NBOMe \u2013 new potent hallucinogenic substance identified on the drug market","volume":"227","author":"Zuba","year":"2013","journal-title":"Forensic Sci. Int."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615016828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615016828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T15:50:45Z","timestamp":1537285845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615016828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":163,"alternative-id":["S0376871615016828"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.030","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next generation of novel psychoactive substances on the horizon \u2013 A complex problem to face","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}